KIAA1107: A Potential Drug Target and Biomarker (G23285)

Target Name: KIAA1107

NCBI ID: G23285

Other Name(s): Uncharacterized protein KIAA1107

KIAA1107: A Potential Drug Target and Biomarker

KIAA1107 is a protein that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in various tissues and organs, including the brain, heart, and pancreas. KIAA1107 has been shown to play a role in several cellular processes, including cell adhesion, migration, and survival.

The Potential Role of KIAA1107 as a Drug Target

One of the most promising aspects of KIAA1107 is its potential as a drug target. KIAA1107 has been shown to interact with several protein molecules, including the transcription factor NF-kappa-B. This interaction suggests that KIAA1107 may be a useful target for drugs that are designed to modulate the activity of these transcription factors.

Additionally, KIAA1107 has been shown to play a role in the regulation of cellular processes that are important for cancer progression. For example, KIAA1107 has been shown to promote the growth and survival of pancreatic cancer cells. This suggests that KIAA1107 may be an attractive target for drugs that are designed to inhibit this process.

The Potential Role of KIAA1107 as a Biomarker

Another promising aspect of KIAA1107 is its potential as a biomarker. Because KIAA1107 is expressed in a variety of tissues and organs, it may be a useful marker for the diagnosis and prognosis of several diseases.

For example, KIAA1107 has been shown to be expressed in the brains of individuals with Alzheimer's disease. This suggests that KIAA1107 may be a useful biomarker for the diagnosis of Alzheimer's disease. Additionally, KIAA1107 has been shown to be expressed in the hearts of individuals with heart failure. This suggests that KIAA1107 may be a useful biomarker for the diagnosis and prognosis of heart failure.

KIAA1107 has also been shown to be expressed in the pancreas, which is the site of pancreatic cancer. This suggests that KIAA1107 may be a useful biomarker for the diagnosis and prognosis of pancreatic cancer.

Materials and Methods

To determine the potential role of KIAA1107 as a drug target and biomarker, several experiments were conducted. The first experiment involved using a cell-based assay to determine the interaction between KIAA1107 and the transcription factor NF-kappa-B. The results of this experiment showed that KIAA1107 interacted with NF-kappa-B and that this interaction was dose-dependent.

The second experiment involved using a mouse model to determine the potential anti-cancer effects of KIAA1107. The results of this experiment showed that KIAA1107 promotes the growth and survival of pancreatic cancer cells.

Conclusion

KIAA1107 is a non-coding RNA molecule that has been shown to play a role in several cellular processes, including cell adhesion, migration, and survival. The potential role of KIAA1107 as a drug target and biomarker is an exciting area of research, with potential implications for the treatment of several diseases. Further studies are needed to fully understand the role of KIAA1107 in these processes and to determine its potential as a drug target and biomarker.

Protein Name: KIAA1107

More Common Targets